CN1421219A - Chinese medicine for treating women's ovary cancer and uterine myoma - Google Patents
Chinese medicine for treating women's ovary cancer and uterine myoma Download PDFInfo
- Publication number
- CN1421219A CN1421219A CN01138718A CN01138718A CN1421219A CN 1421219 A CN1421219 A CN 1421219A CN 01138718 A CN01138718 A CN 01138718A CN 01138718 A CN01138718 A CN 01138718A CN 1421219 A CN1421219 A CN 1421219A
- Authority
- CN
- China
- Prior art keywords
- rhizoma
- radix
- chinese medicine
- gram
- uterine myoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to Chinese medicine and is especially one kind of Chinese medicine for treating women's ovarial tumor and uterine myoma. The Chinese medicine is prepared with 21 kinds of Chinese medicinal materials including saffron, burreed rhizome, ground bettle, nutagrass flatsedge rhizome, bitter orange, etc. The medicine is used in treating women's uterine myoma, overal tumor, ovarial cyst and other diseases; and has high curative effect.
Description
Technical field:
The present invention relates to a kind of middle medicament, particularly a kind of Chinese medicine of specially controlling hysteromyoma of gynecology, oophoroma, ovarian cyst.
Technical background:
At present, hysteromyoma, ovarian cyst, oophoroma are current gynaecological diseases, a kind of common disease that sickness rate is higher.It directly causes symptoms such as metrorrhagia, adnexitis, pelvic inflammatory disease, menoxenia, uterine erosion, leukoplakia vulvae.This kind disease doctor trained in Western medicine is taked operative treatment, and this kind Therapeutic Method is heavy to the patient body injury, the medical expense height.
And current this kind of employing treatment by Chinese herbs disease.All be that these therapies can only be kept symptom, and can not make its recovery from illness with antiinflammatory, blood stasis dispelling, therapy such as invigorate blood circulation mostly.
Suffer from this patient and come from gas more, blood circulation depending on qi flow, stagnation of QI blood ends.So blood stasis deposits in utero, uterine cavity logical, the of a specified duration inflammation of must not relaxing, inflammation is suppurated for a long time, is the disease of cyst.
Summary of the invention:
The objective of the invention is to overcome the Chinese medicinal formulae the deficiencies in the prior art, provide a kind of and can effectively cure various oophoromaes, the Chinese medicine of ovarian cyst and hysteromyoma, cervical erosion.
Technical scheme of the present invention be in prescription, added make the blood stasis dispelling of this kind gynaecopathia disappear heavily fortified point, heat-clearing and toxic substances removing, remove the rotten and let fresh grow, its concrete group part of the Chinese medicine of removing obstruction for relieving pain. and proportioning are as follows: by weight percentage: the west is spent 2-3% mountain first 4-5% turtle shell 8-10% triangular 4-5% literary composition art 4-5% leech 4-5% soil worm 4-5% Da Bei 4-5% root of Dahurain angelica 3-4% rhizoma cyperi 3-4% soap to sting the 3-4% rheum officinale 3-4% Fructus Aurantii 3-4% pseudo-ginseng 3-4% smilax 8-10% Radix Angelicae Sinensis 3-4% Hu 3-4% of unit Radix Glycyrrhizae 2-3% a thousand pieces of gold and is dialled 4-5% radix ampelopsis 4-5% oyster 8-10%
Carapax Trionycis in the side, Squama Manis, Concha Ostreae, Spina Gleditsiae, Radix Notoginseng, has the effect of hard masses softening and resolving, blood stasis dispelling evacuation of pus.Rhizoma sparganic, Rhizoma Curcumae, Stigma Croci, Hirudo have the function of blood circulation promoting and blood stasis dispelling.Bulbus Fritillariae Thunbergii, Radix Flemingiae Philippinensis have the function of detumescence and drawing out poison; The Radix Angelicae Dahuricae has the function of anti-inflammation detumescence.Fructus Aurantii, Rhizoma Cyperi, Rhizoma Corydalis, Radix Et Rhizoma Rhei have the function of dissipating depression of QI circulation of qi promoting.Radix Angelicae Sinensis, Radix Ampelopsis, Rhizoma Smilacis Glabrae have the function of the nourishing kidney of nourishing blood.Radix Glycyrrhizae is concocted all medicines.The present invention supports kidney, active blood stasis dispelling for curing mainly with regulating menstruation and activating blood, eliminating stagnation softening the hard mass, dissipating depression of QI circulation of qi promoting, YIN nourishing.By motherland's theory of Chinese medical science theory: the judgement of " healthy energy internal memory, heresy can not be done, the institute of heresy gathers, its gas must void ".The intrinsic factor that cause this kind gynaecopathia mainly are because seven emotions are disgruntled, injure liver and gall, insufficiency of the spleenly do not take the photograph, and blood-stasis internal-depression, palace gas freely do not wait category.The traditional Chinese medical science thinks that treating this disease answers " hard masses should be treated by softening, stasis of blood person disappears it, disease caused by accumulations of pathogen should be treated with therapy of dispersion, gas person row ".
The present invention compared with prior art has following advantage and good effect:
1, unique curative effect is arranged in clinical practice, suffer from this sick patient and obtained radical cure thereby make, cure rate is more than 90%.
2, the characteristics that have short treating period, instant effect simultaneously, do not recur after more.
The specific embodiment: the west spends the civilian art 25 gram leech of 15 Keshan first, 25 gram turtle shells, 50 gram triangulars, the 25 grams 25 gram eupolyphage sece steleophagas 25 gram Da Bei 25 gram roots of Dahurain angelica 15 gram rhizoma cyperis 15 gram spina gleditsiaes 15 gram rheum officinales 15 gram Fructus Aurantiis 15 gram pseudo-ginseng 20 gram smilaxs 50 gram Radix Angelicae Sinensis 15 gram corydalis tubers 15 gram Radix Glycyrrhizaes 10 gram a thousand pieces of golds to dial 25 gram radix ampelopsis, 25 gram oysters, 50 grams
Above prescription medical material is ground into fine flour, is divided into 1000 parts, is one of finished medicines in the every part of capsule of packing into.Adult's morning and evening every day twice, each 10.Warm water is taken.Avoid Herba Alii fistulosi, Bulbus Allii, raw meat, peppery.
Claims (1)
1, treatment gynecological oophoroma, the Chinese medicine of hysteromyoma, it is characterized in that its component is: by weight percentage: Stigma Croci 2-3%, Squama Manis 4-5%, Carapax Trionycis 8-10%, rhizoma sparganic 4-5%, Rhizoma Curcumae 4-5%, Hirudo 4-5%, eupolyphage sece steleophaga 4-5%, Bulbus Fritillariae Thunbergii 4-5%, Radix Angelicae Dahuricae 3-4%, Rhizoma Cyperi 3-4%, Spina Gleditsiae 3-4%, Radix Et Rhizoma Rhei 3-4%, Fructus Aurantii 3-4%, Radix Notoginseng 3-4%, Rhizoma Smilacis Glabrae 8-10%, Radix Angelicae Sinensis 3-4%, Rhizoma Corydalis 3-4%, Radix Glycyrrhizae 2-3%, a thousand pieces of gold is dialled 4-5%, Radix Ampelopsis 4-5%, Concha Ostreae 8-10%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011387181A CN1219525C (en) | 2001-11-27 | 2001-11-27 | Chinese medicine for treating women's ovary cancer and uterine myoma |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011387181A CN1219525C (en) | 2001-11-27 | 2001-11-27 | Chinese medicine for treating women's ovary cancer and uterine myoma |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1421219A true CN1421219A (en) | 2003-06-04 |
CN1219525C CN1219525C (en) | 2005-09-21 |
Family
ID=4674688
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB011387181A Expired - Fee Related CN1219525C (en) | 2001-11-27 | 2001-11-27 | Chinese medicine for treating women's ovary cancer and uterine myoma |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1219525C (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100350956C (en) * | 2005-12-22 | 2007-11-28 | 陈宝贵 | Medicine for treating hysteromyoma |
CN101332276B (en) * | 2008-07-03 | 2010-09-22 | 沈信堂 | Traditional Chinese medicine for treating uterus tumour |
CN102423369A (en) * | 2011-12-29 | 2012-04-25 | 许从玉 | Traditional Chinese medicine composition for preventing or treating ovarian cancer |
CN102600406A (en) * | 2012-03-29 | 2012-07-25 | 常熟市常福有机复合肥有限公司 | Chinese traditional medicine treating chronic pelvic inflammatory mass and preparation method for Chinese traditional medicine |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023177835A1 (en) * | 2022-03-18 | 2023-09-21 | Smith Nichole | Treatment of uterine fibroids |
-
2001
- 2001-11-27 CN CNB011387181A patent/CN1219525C/en not_active Expired - Fee Related
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100350956C (en) * | 2005-12-22 | 2007-11-28 | 陈宝贵 | Medicine for treating hysteromyoma |
CN101332276B (en) * | 2008-07-03 | 2010-09-22 | 沈信堂 | Traditional Chinese medicine for treating uterus tumour |
CN102423369A (en) * | 2011-12-29 | 2012-04-25 | 许从玉 | Traditional Chinese medicine composition for preventing or treating ovarian cancer |
CN102423369B (en) * | 2011-12-29 | 2012-09-05 | 许从玉 | Chinese medicinal composition for preventing or treating ovarian cancer |
CN102600406A (en) * | 2012-03-29 | 2012-07-25 | 常熟市常福有机复合肥有限公司 | Chinese traditional medicine treating chronic pelvic inflammatory mass and preparation method for Chinese traditional medicine |
CN102600406B (en) * | 2012-03-29 | 2014-02-12 | 常熟市常福有机复合肥有限公司 | Traditional Chinese medicine treating chronic pelvic inflammatory mass and preparation method therefor |
Also Published As
Publication number | Publication date |
---|---|
CN1219525C (en) | 2005-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103349753B (en) | Traditional Chinese medicine composition for treating kidney deficiency | |
CN102068661A (en) | Chinese medical formula for treating female blood stasis, blood deficiency and deep thready pulse dysmenorrhea | |
CN101337045A (en) | Traditional Chinese medicine for treating hyperplasia of mammary glands | |
CN100998656A (en) | Medicated wine for tonifying bone and removing obstruction in channels | |
CN102038911A (en) | Traditional Chinese medicine preparation for treating acute mastitis | |
CN103536748A (en) | Traditional Chinese medicament for treating goiter with depression of liver to generate pathogenic fire | |
CN104306540B (en) | A kind of treat Chinese medicine preparation of numb limbs and tense tendons and preparation method thereof after brain tumor surgery | |
CN102872301B (en) | Anti-rheumatism medicinal liquor and using method thereof | |
CN101632745B (en) | Chinese medicinal compound preparation for treating rheumatic and rheumatoid arthritis | |
CN1421219A (en) | Chinese medicine for treating women's ovary cancer and uterine myoma | |
CN102416146B (en) | Chinese medicinal composition for treating amenorrhea | |
CN102406765B (en) | Traditional Chinese medicine composition for treating acne | |
CN1181842C (en) | A Chinese medicinal honeyed pill for treating aseptic necrosis of femoral head | |
CN103251889A (en) | Traditional Chinese medicine composition for treating agalactia | |
CN101961451A (en) | Kidney-tonifying and body-strengthening oral liquid | |
CN1215875C (en) | Peroral Chinese medicine powder for treating bone fracture and its preparing process | |
CN102552461B (en) | Medicinal moxa roll for treating knee osteoarthritis | |
CN101829249A (en) | Traditional Chinese medicine powder for treating rheumatoid diseases | |
CN101085303A (en) | Oral administration traditional Chinese medicine composition for treating hyperplasia of mammary glands | |
CN102284035A (en) | Chinese composition for treating rhinitis | |
CN1241587C (en) | Chinese medicinal preparation for treating gynopathy | |
CN1382486A (en) | Fengshitongluo wan for treating rheumatism | |
CN1189364A (en) | Pregnancy promoting pill | |
CN105920292A (en) | Chinese medicinal composition for treating acute mastitis | |
CN104758539A (en) | Traditional Chinese medicine composition for treating debilitation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |